Leaderboards/Multiple Sclerosis Research Studies

Multiple Sclerosis Research Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Kathrine E. Attfield
University of Oxford
2
Monica Margoni
Vita-Salute San Raffaele University
3
Samuel Klistorner
The University of Sydney
4
Vito A. G. Ricigliano
Inserm
5
Stefano Ziccardi
University of Verona
6
Fabienne Läderach
University of Zurich
7
Michael Hittle
Stanford University
8
Jack A. Reeves
University at Buffalo, State University of New York
9
Cecilia Smith Simonsen
Drammen Hospital
10
H. J. Kim
University Hospital of Basel

Papers

1
Publication in Multiple Sclerosis Journal (2024) [37 citations, W4391897079]
Multiple Sclerosis Journal|2024
37 cit.
2
Publication in Annals of Neurology (2024) [34 citations, W4392814042]
Annals of Neurology|2024
34 cit.
3
Publication in Neurology (2024) [33 citations, W4403717851]
Neurology|2024
33 cit.
4
Longitudinal enlargement of choroid plexus is associated with chronic lesion expansion and neurodegeneration in RRMS patients
Multiple Sclerosis Journal|2024
17 cit.
5
Publication in Annals of Clinical and Translational Neurology (2024) [12 citations, W4402582734]
Annals of Clinical and Translational Neurology|2024
12 cit.
6
The influence of menopause on multiple sclerosis
European Journal of Neurology|2024
12 cit.
7
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study
Brain Communications|2024
11 cit.
8
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage
Neurology Neuroimmunology & Neuroinflammation|2024
9 cit.
9
Publication in Molecular Psychiatry (2024) [8 citations, W4393158965]
Molecular Psychiatry|2024
8 cit.
10
Publication in Annals of Clinical and Translational Neurology (2024) [8 citations, W4404468885]
Annals of Clinical and Translational Neurology|2024
8 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Peer Baneke
Multiple Sclerosis International Federation
2
Marianna Cortese
Harvard University
3
Melinda Magyari
University of Copenhagen
4
Nynke F. Kalkers
OLVG
5
Gonçalo Castelo‐Branco
Karolinska Institutet
6
Menno M. Schoonheim
Amsterdam Neuroscience
7
Madeline A. Lancaster
MRC Laboratory of Molecular Biology
8
Robert A Bermel
Cleveland Clinic
9
Mireille Desille‐Dugast
Inserm
10
Ju‐Hong Min
Samsung (South Korea)

Papers

1
How patients with multiple sclerosis acquire disability
Brain|2022
528 cit.
2
Multimodal chromatin profiling using nanobody-based single-cell CUT&Tag
Nature Biotechnology|2022
133 cit.
3
Androgens increase excitatory neurogenic potential in human brain organoids
Nature|2022
121 cit.
4
Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology
Cell|2024
105 cit.
5
Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility
Neuron|2022
100 cit.
6
Tissue morphology influences the temporal program of human brain organoid development
Cell stem cell|2023
95 cit.
7
Developmental landscape of human forebrain at a single-cell level identifies early waves of oligodendrogenesis
Developmental Cell|2022
82 cit.
8
Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis
Journal of Neurology Neurosurgery & Psychiatry|2022
61 cit.
9
Spatial and temporal heterogeneity in the lineage progression of fine oligodendrocyte subtypes
BMC Biology|2022
60 cit.
10
Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study
Multiple Sclerosis and Related Disorders|2022
41 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Jerry S. Wolinsky
The University of Texas Health Science Center at Houston
2
Brian G. Weinshenker
Mayo Clinic in Arizona
3
Massimo Filippi
Vita-Salute San Raffaele University
4
Robert W. Motl
University of Illinois Chicago
5
George C. Ebers
John Radcliffe Hospital
6
Ludwig Kappos
University Hospital of Basel
7
Alan J. Thompson
Queen Mary University of London
8
Frederik Barkhof
National Hospital for Neurology and Neurosurgery
9
Xavier Montalbán
Universitat de Vic - Universitat Central de Catalunya
10
Alberto Ascherio
Brigham and Women's Hospital

Papers

1
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Annals of Neurology|2011
9.8k cit.
2
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
Annals of Neurology|2001
7k cit.
3
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Neurology|2015
4.5k cit.
4
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
The Lancet|2004
3.2k cit.
5
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
New England Journal of Medicine|2010
2.6k cit.
6
Revised diagnostic criteria for neuromyelitis optica
Neurology|2006
2.6k cit.
7
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
New England Journal of Medicine|2010
2.2k cit.
8
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
The Lancet|1998
2.1k cit.
9
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
Science|2022
2k cit.
10
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
New England Journal of Medicine|2016
2k cit.

Reagents for Multiple Sclerosis Research Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

RocklandEvidence 66

Anti-KANK3 (RABBIT) Antibody - 600-401-CD4

Cited in 5 papers
#600-401-CD4
View Evidence →
BioLegend

Purified (azide-free) anti-Neurofilament H (NF-H), Nonphosphorylated

Cited in 5 papers
#801701 (also 801702)
View Evidence →
Millipore

Anti-Alzheimer Precursor Protein A4, a.a. 66-81 of APP {N-terminus}, clone 22C11

Cited in 5 papers
#MAB348
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

VGLUT2 (D7D2H) Rabbit Monoclonal Antibody

Cited in 22 papers
#71555$161,351
View Evidence →
MilliporeEvidence 67

Anti-Olig-2 Antibody

Cited in 7 papers
#AB9610
View Evidence →
Acris AntibodiesEvidence 60

Mouse Anti-Canine Distemper Virus Monoclonal Antibody, Unconjugated, Clone 40026

Cited in 5 papers
#3CD10-8-1
View Evidence →